The banking of arterial allografts in the United Kingdom. A technical and clinical review

Cell and Tissue Banking

Volumn 1, Issue 4, 2000, Pages 295-301

  Wusteman, M C ^a   Pegg, D E ^a,b   Warwick, R M ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Allograft; Cryopreservation; Immunosuppression; Tissue banking; Vascular surgery

Indexed keywords

EID: 25844511766     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bateson EAJ and Pegg DE (1994) Cryopreservation of arteries: selection of a model for human small elastic arteries and preliminary results of preservation of ring- segments with dimethyl sulphoxide. CryoLetters 15: 15-26
2. Bilfinger TV, Hartman AR, Liu Y et al. (1997) Cryopreserved veins in myocardial revascularization: possible mechanisms for their increased failure. Ann Thorac Surg 63: 1063-1069
3. British Association for Tissue Banking (1999) General Standards for Tissue Banking (see also Technical Guidelines for Cardiovascular, Skeletal and Skin Banking, for Aseptic Processing, Sterilisation, and Donor Selection)
4. Brockbank KGM, Donovan TJ, Ruby ST et al. (1990) Functional analysis of cryopreserved veins: preliminary report. J Vase Surg 11: 94-102
5. Brockbank KGM, McNally RT and Walsh KA (1992) Cryopreserved vein transplantation. J Cardiac Surg 7: 170-176
6. Carpenter JP and Tomaszewski JE (1997) Immunosuppression for human saphenous vein allograft bypass surgery: a prospective randomised trial. J Vase Surg 26: 320-342
7. Carpenter JP and Tomaszewski JE (1998) Human saphenous vein allograft bypass grafts: immune response. J Vase Surg 27: 492-499
8. Chiesa R, Astore D, Piccolo G et al. (1998) Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vase Surg 12: 457-462
9. Committee on Microbiological Safety of Blood and Tissues for Transplantation, Department of Health: Guidance on the microbiological safety of human tissues and organs used in transplantation. NHS Executive, March 1996 (Revised guidance is due for publication in 2000)
10. Couvelard A, Leseche G, Scoazec JY et al. (1995) Human allograft vein failure: immunohistochemical arguments supporting the involvement of an immune-mediated mechanism. Hum Pathol 26: 1313-1320
11. Da Gama DA, Sarmento C, Viera T et al. (1994) The use of arterial allografts for vascular reconstruction in patients receiving immunosuppression for organ transplantation. J Vase Surg 20: 271-278
12. Davies MG and Hagen P-O (1994) Structural and functional consequences of by-pass grafting with autologous vein. Cryobiology 31: 63-70
13. Dzimiri N, Chester AH, Allen SP et al. (1996) Vascular reactivity of arterial by-pass grafts-implications for their performance. Clin Cardiol 19: 165-171
14. Elmore JR, Gloviczki P, Brockbank KGM et al. (1992) Functional changes in canine saphenous veins after cryopreservation. Int Angiol II: 26-35
15. Fehily D and Warwick RM (1997) Safe tissue grafts: should achieve the same standards as for blood transfusion. Brit Med J 314: 1141-1142
16. Goffin YA, Grandmougin D, Wozniak G et al. (1998) Banking and distribution of large arterial homografts in Brussels. Vascular Surgery 32: 19-32
17. Good NE, Winget GD, Winter W, Connolly TN, Izawa S and Singh RMM (1966) Hydrogen ion buffers for biological research. J Biochem 5: 467-477
18. Gournier J-P, Favre J-P, Gay J-L et al. (1995) Cryopreserved arterial allografts for limb salvage in the absence of suitable saphenous vein: two year results in 20 cases. Ann Vase Surg 9: S7-S14
19. Harris RW, Schneider PA, Andros G et al. (1993) Allograft vein bypass: is it an acceptable alternative for infrapopliteal revascularization? J Vase Surg 18: 553-560
20. Hogan P, Duplock L, Green M, Smith S, Gall KL, Frazer IH, O'Brien MF (1996) Human aortic valve allografts elicit a donor specific immune response. J Thorac Cardiovasc Surg 112: 1260-1267
21. Hunt CJ, Song YC, Bateson EAJ and Pegg DE (1994) Fractures in cryopreserved arteries. Cryobiology 31: 506-515
22. laffaldano RA, Lewis BE, Johnson SA et al. (1995) Patency of cryopreserved saphenous vein grafts as conduits for coronary artery bypass surgery. Chest 108: 725-729
23. Ku DD, Willis WL and Caulfield JB (1990) Retention of endothelium-dependant vasodilatory responses in canine coronary arteries following cryopreservation. Cryobiology 27: 511-520
24. Lehalle B, Geschier C, Fiévé G et al. (1997) Early rupture and degeneration of cryopreserved arterial allografts. Vasc Surg 25: 751-752
25. Leseche G, Penna C, Bouttier S, Joubert S and Andreassian B (1997) Femorodistal bypass using cryopreserved venous allografts for limb salvage. Ann Vase Surg 11: 230-236
26. Loop FD, Lyttle BW, Cosgrove DM et al. (1986) Influence of the internal mammary graft on 10 year survival and other cardiac events. New Eng J Med 314: 1-6
27. Martin RS, Edwards WH, Mulherin JL et al. (1994) Cryopreserved saphenous vein allografts for below-knee extremity revascularization. Ann Surg 219: 664-672
28. Matsuura JH, Johansen KH, Rosenthal D, Clark MD, Clarke KA and Kirby LB (2000) Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg 14: 50-55
29. Mestres C-A, Mulet J and Pomar JL (1995) Large calibre cryopreserved arterial allografts in vascular reconstructive operations: early experience. Ann Thorac Surg 60: S105-S107
30. Miller VM, Bergman RT, Gloviczki P et al. (1993) Cryopreserved venous allografts: effects of immunosuppression and anti-platelet therapy on patency and function. J Vase Surg 18: 216-226